Biodel seeks FDA advertising approval for VIAject Biodel Inc.

Biodel seeks FDA advertising approval for VIAject Biodel Inc. announced today that the U.S. It’s been tested in more than 875 sufferers who participated in Stage 1, 2 and 3 clinical trials of the medication in the usa, India and Germany. Biodel on December 30 submitted its marketing program to the FDA, 2009 and expects the Prescription Medication User Fee Work action date because of this October 30 NDA to be, 2010.‘I haven’t had pain for 13 years and I maneuver around better now at 65 then I did at 52.’ The Mayo Clinic provides more info on osteoarthritis.

CINJ receives $75,000 grant from Breast Cancer Alliance For the next consecutive year, The Cancer Institute of NJ has been awarded a $75,000 grant from the non-profit entity the Breast Cancer Alliance. The grant, which supports the institute's Breast Medical procedures Fellowship Plan, is for academic 12 months 2013-2014. The Malignancy Institute of NJ is a Middle of Excellence of The University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School. The one-year fellowship system provides surgeons who’ve completed their general medical procedures residency with advanced schooling and experience that prepares them to supply comprehensive care specifically for patients with breasts disease.